Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 37,427 | 15,762 | 23,800 | 21,700 | 10,000 |
| Cost of Goods | 10,498 | 5,067 | N/A | N/A | N/A |
| Gross Profit | 26,929 | 10,695 | 23,800 | 21,700 | 10,000 |
| Operating Expenses | 265,419 | 236,178 | 200,942 | 149,805 | 146,842 |
| Operating Income | -237,992 | -225,416 | -177,142 | -128,105 | -136,842 |
| Other Income | -13,108 | -6,164 | 6,905 | 4,532 | 2,197 |
| Pre-tax Income | -251,100 | -231,580 | -170,237 | -123,573 | -134,645 |
| Income Tax | 22 | 114 | 58 | 57 | -336 |
| Net Income Continuous | -251,122 | -231,694 | -170,295 | -123,630 | -134,309 |
| Net Income | $-251,122 | $-231,694 | $-170,295 | $-123,630 | $-134,309 |
| EPS Basic Total Ops | -2.45 | -2.29 | -1.93 | -1.72 | -2.18 |
| EPS Basic Continuous Ops | -2.45 | -2.29 | -1.89 | -1.72 | -2.18 |
| EPS Diluted Total Ops | -2.45 | -2.29 | -1.93 | -1.72 | -2.18 |
| EPS Diluted Continuous Ops | -2.45 | -2.29 | -1.89 | -1.72 | -2.18 |
| EPS Diluted Before Non-Recurring Items | -2.45 | -2.29 | -1.93 | -1.72 | -2.18 |
| EBITDA(a) | $-230,985 | $-221,119 | $-179,440 | $-128,609 | $-134,938 |